BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18257959)

  • 1. The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vagal complex of rats: implications for olanzapine-induced weight gain.
    Weston-Green K; Huang XF; Han M; Deng C
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):827-35. PubMed ID: 18257959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine treatment decreases the density of muscarinic M2 receptors in the dorsal vagal complex of rats.
    Deng C; Weston-Green KL; Han M; Huang XF
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):915-20. PubMed ID: 17368684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine-activated AMPK signaling in the dorsal vagal complex is attenuated by histamine H1 receptor agonist in female rats.
    He M; Zhang Q; Deng C; Wang H; Huang XF
    Endocrinology; 2014 Dec; 155(12):4895-904. PubMed ID: 25264935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-dependent effects of olanzapine treatment on the expression of histidine decarboxylase, H1 and H3 receptor in the rat brain: The roles in olanzapine-induced obesity.
    He M; Zhang Q; Deng C; Jin T; Song X; Wang H; Huang XF
    Psychoneuroendocrinology; 2017 Nov; 85():190-199. PubMed ID: 28886461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of olanzapine on muscarinic M3 receptor binding density in the brain relates to weight gain, plasma insulin and metabolic hormone levels.
    Weston-Green K; Huang XF; Lian J; Deng C
    Eur Neuropsychopharmacol; 2012 May; 22(5):364-73. PubMed ID: 21982116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain.
    Weston-Green K; Huang XF; Deng C
    PLoS One; 2012; 7(3):e33548. PubMed ID: 22438946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression.
    Han M; Deng C; Burne TH; Newell KA; Huang XF
    Psychoneuroendocrinology; 2008 Jun; 33(5):569-80. PubMed ID: 18358632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats.
    Choi S; DiSilvio B; Unangst J; Fernstrom JD
    Life Sci; 2007 Sep; 81(12):1024-30. PubMed ID: 17822717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of antipsychotics on the density of cannabinoid receptors in selected brain regions of male and female adolescent juvenile rats.
    Lian J; Deng C
    Psychiatry Res; 2018 Aug; 266():317-322. PubMed ID: 29576413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of thermogenesis in antipsychotic drug-induced weight gain.
    Stefanidis A; Verty AN; Allen AM; Owens NC; Cowley MA; Oldfield BJ
    Obesity (Silver Spring); 2009 Jan; 17(1):16-24. PubMed ID: 19107124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment.
    Minet-Ringuet J; Even PC; Valet P; Carpéné C; Visentin V; Prévot D; Daviaud D; Quignard-Boulange A; Tomé D; de Beaurepaire R
    Mol Psychiatry; 2007 Jun; 12(6):562-71. PubMed ID: 17211438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone treatment increases CB1 receptor binding in rat brain.
    Secher A; Husum H; Holst B; Egerod KL; Mellerup E
    Neuroendocrinology; 2010; 91(2):155-68. PubMed ID: 19815998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two models for weight gain and hyperphagia as side effects of atypical antipsychotics in male rats: validation with olanzapine and ziprasidone.
    Shobo M; Yamada H; Mihara T; Kondo Y; Irie M; Harada K; Ni K; Matsuoka N; Kayama Y
    Behav Brain Res; 2011 Jan; 216(2):561-8. PubMed ID: 20816897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications.
    Lian J; Huang XF; Pai N; Deng C
    Pharmacol Res; 2016 Apr; 106():51-63. PubMed ID: 26892184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.
    Assié MB; Carilla-Durand E; Bardin L; Maraval M; Aliaga M; Malfètes N; Barbara M; Newman-Tancredi A
    Eur J Pharmacol; 2008 Sep; 592(1-3):160-6. PubMed ID: 18640111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term treatment with olanzapine mixed with the food in male rats induces body fat deposition with no increase in body weight and no thermogenic alteration.
    Minet-Ringuet J; Even PC; Goubern M; Tomé D; de Beaurepaire R
    Appetite; 2006 May; 46(3):254-62. PubMed ID: 16551485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-lowering effects of tetradecylthioacetic acid in antipsychotic-exposed, female rats: challenges with long-term treatment.
    Skrede S; Fernø J; Bjørndal B; Brede WR; Bohov P; Berge RK; Steen VM
    PLoS One; 2012; 7(11):e50853. PubMed ID: 23226405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats.
    Skrede S; Fernø J; Vázquez MJ; Fjær S; Pavlin T; Lunder N; Vidal-Puig A; Diéguez C; Berge RK; López M; Steen VM
    Int J Neuropsychopharmacol; 2012 Mar; 15(2):163-79. PubMed ID: 21854679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.
    Deng C; Lian J; Pai N; Huang XF
    J Psychopharmacol; 2012 Sep; 26(9):1271-9. PubMed ID: 22695490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
    McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
    J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.